Jeffrey M. Leiden, Executive Chairman at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 65,084 shares at $287.23 ($18.6M) on 2020-06-30, disclosed to the SEC on 2020-07-02.
Open-market sale of $18.6M VRTX by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $284.14 | 5,801 | $1.6M | 8.9% |
| 2 | $284.14 | 5,801 | $1.6M | 8.9% |
| 3 | $285.11 | 9,233 | $2.6M | 14.1% |
| 4 | $285.11 | 9,233 | $2.6M | 14.1% |
| 5 | $286.13 | 8,321 | $2.4M | 12.8% |
| 6 | $286.13 | 8,321 |
| $2.4M |
| 12.8% |
| 7 | $287.23 | 4,885 | $1.4M | 7.5% |
| 8 | $287.23 | 4,885 | $1.4M | 7.5% |
| 9 | $287.91 | 1,318 | $379K | 2.0% |
| 10 | $287.91 | 1,318 | $379K | 2.0% |
| 11 | $289.39 | 500 | $145K | 0.8% |
| 12 | $290.51 | 2,534 | $736K | 4.0% |
| 13 | $290.51 | 2,534 | $736K | 4.0% |
| 14 | $291.34 | 200 | $58K | 0.3% |
| 15 | $291.34 | 200 | $58K | 0.3% |
| Total | $286.12 avg | 65,084 | $18.6M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |